Search research articles
Contact Us
Filters
Showing results (11-20 of 27) with videos related to
Page
of 3
Sort By:
Diagnostics (Basel, Switzerland)
|
July 2, 2021
Regulation of Platelet-Derived ADAM17: A Biomarker Approach for Breast Cancer?
Yanjun Zhou, Jonas S Heitmann, Korbinian N Kropp, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 22, 2025
Histologic Ex Vivo Validation of the [<sup>18</sup>F]SITATE Somatostatin Receptor PET Tracer
Nils F Trautwein, Sven Mattern, Martina Hinterleitner, et al.
Current Oncology (Toronto, Ont.)
|
February 26, 2026
Primary Renal Neuroendocrine Tumor: Diagnostic Challenges in a Rare Entity-A Case Report
Raphaela D Lewetag, Katharina Kluthe, Nils F Trautwein, et al.
Frontiers in Endocrinology
|
January 23, 2024
Treatment modalities favoring outcome in well-differentiated neuroendocrine tumors G3
Martina Hinterleitner, Ruben Pfeiffer, Nils F Trautwein, et al.
Frontiers in Oncology
|
April 5, 2021
Platelet-Expressed TNFRSF13B (TACI) Predicts Breast Cancer Progression
Clemens Hinterleitner, Yanjun Zhou, Claudia Tandler, et al.
Cancers
|
December 30, 2025
Cardiac Metastases in Neuroendocrine Neoplasms: A Single-Center Experience of Clinical Characteristics and Outcomes
Raphaela D Lewetag, Nils F Trautwein, Monika Zdanyte, et al.
Cancer Immunology, Immunotherapy : CII
|
February 4, 2021
Platelet-expressed immune checkpoint regulator GITRL in breast cancer
Yanjun Zhou, Jonas S Heitmann, Kim L Clar, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
January 30, 2025
One-day dual-tracer examination in neuroendocrine neoplasms: a real advantage of low activity LAFOV PET imaging
Eduardo Calderón, Lena S Kiefer, Fabian P Schmidt, et al.
Clinical Nuclear Medicine
|
January 25, 2024
Radiosensitizing Favors Response to Peptide Receptor Radionuclide Therapy in Patients With Highly Proliferative Neuroendocrine Malignancies: Preliminary Evidence From a Clinical Pilot Study
Nils Florian Trautwein, Clemens Hinterleitner, Lena Sophie Kiefer, et al.
Frontiers in Oncology
|
July 25, 2022
Controversial Role of the Immune Checkpoint OX40L Expression on Platelets in Breast Cancer Progression
Susanne M Rittig, Martina S Lutz, Kim L Clar, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 27) with videos related to
Sort By:
Page
of 3
Diagnostics (Basel, Switzerland)
|
July 2, 2021
Regulation of Platelet-Derived ADAM17: A Biomarker Approach for Breast Cancer?
Yanjun Zhou, Jonas S Heitmann, Korbinian N Kropp, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 22, 2025
Histologic Ex Vivo Validation of the [<sup>18</sup>F]SITATE Somatostatin Receptor PET Tracer
Nils F Trautwein, Sven Mattern, Martina Hinterleitner, et al.
Current Oncology (Toronto, Ont.)
|
February 26, 2026
Primary Renal Neuroendocrine Tumor: Diagnostic Challenges in a Rare Entity-A Case Report
Raphaela D Lewetag, Katharina Kluthe, Nils F Trautwein, et al.
Frontiers in Endocrinology
|
January 23, 2024
Treatment modalities favoring outcome in well-differentiated neuroendocrine tumors G3
Martina Hinterleitner, Ruben Pfeiffer, Nils F Trautwein, et al.
Frontiers in Oncology
|
April 5, 2021
Platelet-Expressed TNFRSF13B (TACI) Predicts Breast Cancer Progression
Clemens Hinterleitner, Yanjun Zhou, Claudia Tandler, et al.
Cancers
|
December 30, 2025
Cardiac Metastases in Neuroendocrine Neoplasms: A Single-Center Experience of Clinical Characteristics and Outcomes
Raphaela D Lewetag, Nils F Trautwein, Monika Zdanyte, et al.
Cancer Immunology, Immunotherapy : CII
|
February 4, 2021
Platelet-expressed immune checkpoint regulator GITRL in breast cancer
Yanjun Zhou, Jonas S Heitmann, Kim L Clar, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
January 30, 2025
One-day dual-tracer examination in neuroendocrine neoplasms: a real advantage of low activity LAFOV PET imaging
Eduardo Calderón, Lena S Kiefer, Fabian P Schmidt, et al.
Clinical Nuclear Medicine
|
January 25, 2024
Radiosensitizing Favors Response to Peptide Receptor Radionuclide Therapy in Patients With Highly Proliferative Neuroendocrine Malignancies: Preliminary Evidence From a Clinical Pilot Study
Nils Florian Trautwein, Clemens Hinterleitner, Lena Sophie Kiefer, et al.
Frontiers in Oncology
|
July 25, 2022
Controversial Role of the Immune Checkpoint OX40L Expression on Platelets in Breast Cancer Progression
Susanne M Rittig, Martina S Lutz, Kim L Clar, et al.
Page
of 3